Williams L Keoki, Joseph Christine L, Peterson Edward L, Wells Karen, Wang Mingqun, Chowdhry Vimal K, Walsh Matthew, Campbell Janis, Rand Cynthia S, Apter Andrea J, Lanfear David E, Tunceli Kaan, Pladevall Manel
Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA.
J Allergy Clin Immunol. 2007 Nov;120(5):1153-9. doi: 10.1016/j.jaci.2007.08.020. Epub 2007 Oct 22.
Adherence to inhaled corticosteroids (ICSs) is known to be poor among patients with asthma; however, little is known about patients who do not fill their ICS prescriptions (ie, primary nonadherence).
To estimate rates of primary nonadherence and to explore associated factors.
The study population was members of a large health maintenance organization in southeast Michigan who met the following criteria: age 5 to 56 years; previous diagnosis of asthma; at least 1 electronic prescription for an ICS between February 17, 2005, and June 1, 2006; and at least 3 months follow-up after the ICS prescription. Adherence was estimated by using electronic prescription information and pharmacy claims data. Multivariable stepwise analysis was used to identify factors associated with primary nonadherence compared with adherent patients.
One thousand sixty-four patients met the study criteria and had calculable adherence. Of these patients, 82 (8%) never filled their ICS prescription. Stepwise regression identified the following factors to be associated with an increased likelihood of primary nonadherence: younger age, female sex, African American race-ethnicity, and lower rescue medication use. Factors associated with primary nonadherence differed between race-ethnic groups.
Primary nonadherence was associated with lower baseline rescue medication use, which may reflect lower perceived need for ICS therapy in patients with milder asthma. Rates of primary nonadherence and the factors which influenced this outcome differed by race-ethnicity.
Understanding patient characteristics associated with primary nonadherence may be important for disease management, because many patients with asthma do not fill their ICS prescriptions.
已知哮喘患者吸入性糖皮质激素(ICS)的依从性较差;然而,对于未取ICS处方的患者(即初始不依从)了解甚少。
评估初始不依从率并探索相关因素。
研究人群为密歇根州东南部一家大型健康维护组织的成员,他们符合以下标准:年龄5至56岁;既往有哮喘诊断;在2005年2月17日至2006年6月1日期间至少有1张ICS电子处方;ICS处方后至少有3个月的随访。通过使用电子处方信息和药房报销数据评估依从性。采用多变量逐步分析来确定与依从患者相比初始不依从相关的因素。
1064名患者符合研究标准且有可计算的依从性。在这些患者中,82名(8%)从未取过ICS处方。逐步回归确定以下因素与初始不依从可能性增加相关:年龄较小、女性、非裔美国人种族以及急救药物使用较少。种族群体之间与初始不依从相关的因素有所不同。
初始不依从与较低的基线急救药物使用相关,这可能反映出哮喘较轻患者对ICS治疗的需求感知较低。初始不依从率及影响该结果的因素因种族而异。
了解与初始不依从相关的患者特征对于疾病管理可能很重要,因为许多哮喘患者未取ICS处方。